Melinda Jasper
Chief Tech/Sci/R&D Officer at RHS LTD
Profile
Melinda Jasper is currently the Chief Scientific Officer at PerkinElmer Health Sciences (Australia) Pty Ltd.
She started this position in 2014.
Prior to her current role, she worked as a Principal at the University of Adelaide and as a Senior Research Scientist at RHS Subsidiary Pty Ltd.
Melinda Jasper active positions
| Companies | Position | Start |
|---|---|---|
| RHS LTD | Chief Tech/Sci/R&D Officer | 01/01/2012 |
Former positions of Melinda Jasper
| Companies | Position | End |
|---|---|---|
| University of Adelaide | Corporate Officer/Principal | - |
RHS Subsidiary Pty Ltd.
 RHS Subsidiary Pty Ltd. Medical/Nursing ServicesHealth Services RHS Subsidiary Pty Ltd. engages in the development of patented technology for single cell chromosome analysis. It has developed a robust and simple whole genome amplification polymerase chain reaction (PCR) system and microarray to accurately and reliably screen the number of chromosomes present in a single human cell. The company was founded in 2003 and is headquartered in Thebarton, Australia. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
RHS Subsidiary Pty Ltd.
RHS Subsidiary Pty Ltd. Medical/Nursing ServicesHealth Services RHS Subsidiary Pty Ltd. engages in the development of patented technology for single cell chromosome analysis. It has developed a robust and simple whole genome amplification polymerase chain reaction (PCR) system and microarray to accurately and reliably screen the number of chromosomes present in a single human cell. The company was founded in 2003 and is headquartered in Thebarton, Australia. | Health Services |
PerkinElmer Health Sciences (Australia) Pty Ltd.
 PerkinElmer Health Sciences (Australia) Pty Ltd. BiotechnologyHealth Technology PerkinElmer Health Sciences (Australia) Pty Ltd. engages in the research, development, and commercialization of single cell genomic technologies. It offers PG-Seq, DOPlify, and EmbryoCellect, products training and TDS & instructional videos. The company was founded on March 21, 1980 and is headquartered in Thebarton, Australia. | Health Technology |
- Stock Market
- Insiders
- Melinda Jasper
